LCM
IART icon

Landscape Capital Management’s Integra LifeSciences IART Stock Holding History

Landscape Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-173,883
Closed -$9.71M – 724
2019
Q2 		$9.71M Buy
+173,883
New +$8.95M 0.77% 11
2018
Q4 		– Sell
-4,212
Closed -$277K – 912
2018
Q3 		$277K Buy
+4,212
New +$262K 0.02% 573

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Landscape Capital Management's IART Position: Q3 2019 in Review

Landscape Capital Management sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 173,883 shares — an estimated $9.71M sold.

Landscape Capital Management first reported a position in IART in Q3 2018 and held it in 2 quarters. The position peaked at $9.71M in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Landscape Capital Management reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
  • Landscape Capital Management sold 173,883 Integra LifeSciences shares in Q3 2019, an estimated $9.71M.
  • Landscape Capital Management first reported a position in Integra LifeSciences in Q3 2018 and held it in 2 quarters.
  • Landscape Capital Management's Integra LifeSciences position peaked at $9.71M in Q2 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Landscape Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.